Omnicare : Omnicare's Series A and Series B Trust PIERS to Accrue Contingent Interest

 Omnicare : Omnicare's Series A and Series B Trust PIERS to Accrue Contingent

CINCINNATI, July 10, 2013 - Omnicare, Inc. (NYSE: OCR) announced today that
for the period from June 15, 2013 to September 14, 2013 its Series A and
Series B Trust Preferred Income Equity Redeemable Securities (NYSE: OCR.PRA
and OCR.PRB) (the "Trust PIERS") will, subject to the terms of the Trust
PIERS, accrue contingent interest at a rate of 0.125% of the average trading
price of the Trust PIERS for the five trading days ended June 13, 2013, in
addition to the continued accrual of regular cash interest. Contingent cash
interest, which Omnicare has determined to be approximately $0.07 per $50
stated liquidation amount of Trust PIERS, will be payable to holders of the
Trust PIERS as of the record date, which is September 13, 2013. The payment
of contingent cash interest is expected to be made on September 16, 2013.

About Omnicare

Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides
comprehensive pharmaceutical services to patients and providers across North
America. As the market-leader in professional pharmacy, related consulting
and data management services for skilled nursing, assisted living and other
chronic care institutions, Omnicare leverages its unparalleled clinical
insight into the geriatric market along with some of the industry's most
innovative technological capabilities to the benefit of its long-term care
customers. Omnicare also provides key commercialization services for the
bio-pharmaceutical industry and end-of-life disease management through its
Specialty Care Group. For more information, visit

                                    # # #

Patrick C. Lee
(513) 719-1507


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Omnicare via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.